Search results
53 results found.
53 results found.
We have been discussing the costs associated with COVID-19 for nearly two years. Earlier this year, we covered how the ongoing pandemic has affected employment and insurance status of millions of Americans. Now federal funds for vaccines, testing, and treatment of the novel coronavirus have run out and additional funding has failed to pass through Congress, leaving the 28 million uninsured Americans responsible for paying the costs themselves. For most of the public health crisis even uninsured patients could receive free preventative vaccines, tests to detect the coronavirus, and treatment if infected. Unfortunately, this information hadn’t been widely circulated […]
The ongoing coronavirus pandemic has affected nearly every aspect of our lives. While the economy has been a frequent topic of fallout throughout the ongoing pandemic in the United States, the reality for lives of workers who have lost their jobs due to the pandemic is often overlooked or erroneously blamed on an unwillingness to work. Roughly 9.6 million American workers lost their jobs in the first year of the COVID-19 pandemic, increasing the unemployment rate from 3.8% in 2019 to 8.6% in 2020. Not only did 23% of those who lost their jobs due to the pandemic not […]
Everyone has stress and difficult emotions on occasion, and this is completely normal. Mental illness, however, is any condition that makes it difficult to function in daily life. It can affect relationships or job performance, and is caused by any number of complex interactions within the human brain. Mental illness can range from anxiety to mood disorders like depression, psychotic disorders like schizophrenia, eating disorders, or addictive behaviors. Studies have shown the economic costs of untreated mood and anxiety disorders among moms exceeds $14 billion dollars through the first five years of a child’s life alone, and fewer adults […]
In a blog posted here on May 16, 2023 I discussed the phasing out of the January 2020 Federal Government COVID-19 public health emergency. At that time The Food and Drug Administration (FDA) continued to authorize the COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid) for emergency use. It has since been fully approved for adults with Covid at high risk of hospitalization or death, such as older adults and those with medical conditions like diabetes, asthma, and obesity. The government continued to provide Paxlovid at no cost to patients until November 1, 2023. Insurance companies will now be able to charge for […]
The Federal Government declared a COVID-19 public health emergency in January of 2020 and decreed many changes in healthcare and healthcare insurance to help people better cope with the pandemic. The Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 provided $6.7 billion for the federal and state governments to respond to the COVID epidemic in the United States. An additional $1.6 billion was included to contribute to the international response. The majority of the funds were used to control the virus in the form of research into treatment and prevention measures; keeping track of all aspects of the […]